Fungal infections in neutropenia: current problems and chemotherapeutic control

D W Warnock1

  • 1Public Health Laboratory, Kingsdown, Bristol, UK.

Insights

Invasive fungal infections pose a serious threat to neutropenic patients, caused by fungi like Aspergillus and Candida. This review covers clinical signs, diagnosis, and treatment strategies, including antifungal medications.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Hematology

Background:

  • Invasive fungal infections (IFIs) are a major cause of morbidity and mortality in neutropenic individuals.
  • Common pathogens include Aspergillus and Candida species, with increasing reports of Fusarium and Trichosporon infections.

Purpose of the Study:

  • To describe the clinical manifestations of IFIs in neutropenic patients.
  • To discuss diagnostic challenges associated with these infections.
  • To review current and emerging treatment and prevention strategies for IFIs.

Main Methods:

  • Literature review of clinical manifestations, diagnostic approaches, and therapeutic options for IFIs in neutropenic populations.
  • Analysis of the role of specific antifungal agents, including lipid formulations of amphotericin B and triazoles (itraconazole, fluconazole).

Main Results:

  • IFIs present with diverse clinical symptoms, often posing diagnostic difficulties.
  • Antifungal therapies, particularly lipid-based amphotericin B and triazoles, are crucial for management and prophylaxis.

Conclusions:

  • Effective management of IFIs in neutropenic patients requires prompt diagnosis and appropriate antifungal therapy.
  • Ongoing research into novel treatments and preventative measures is essential to combat the rising incidence of IFIs.

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...